About
Jacinta Jacob is a researcher with significant contributions to immunology and microbiology, particularly in regulatory T cells, allorecognition, and post-COVID-19 syndrome. She has collaborated extensively with networks like the PHOSP-COVID Study collaborative group and ISARIC4C Investigators, publishing in high-impact journals such as Immunity and Ageing and The Lancet Regional Health - Europe.
- Key Expertise: Regulatory T cells (100%), Immune aging (100%), Post-COVID-19 recovery (100%)
- Collaborations: 279+ researchers across UK institutions (2024); 276+ collaborators in 2023
Research Trends: Her work focuses on immune cell dynamics in viral infections, transplantation immunology, and long-term post-viral effects. Articles analyze CD8 T cells, interleukin-2 therapy, and PAR-4 receptor modulation of Tregs.
Public Impact: Research widely shared by 473+ X (Twitter) users, 2 Facebook pages, and covered in 1 news outlet. Cited 134 times (Scopus).
